HRSA/OPA recently conducted a 340B Recertification webinar for Title X Family Planning Grantees. Recertification for Title X Family Planning will begin May 13 and end June 10. You may access the recording of the webinar here.
The 340B Drug Pricing Program requires drug manufacturers to provide outpatient drugs to eligible health care organizations/covered entities at significantly reduced prices.
The 340B Program enables covered entities to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.
Eligible health care organizations/covered entities are defined in statute and include HRSA-supported health centers and look-alikes, Ryan White clinics and State AIDS Drug Assistance programs, Medicare/Medicaid Disproportionate Share Hospitals, children’s hospitals, and other safety net providers. See the full list of eligible organizations/covered entities.
To participate in the 340B Program, eligible organizations/covered entities must register and be enrolled with the 340B program and comply with all 340B Program requirements. Once enrolled, covered entities are assigned a 340B identification number that vendors verify before allowing an organization to purchase 340B discounted drugs.
New registrations are accepted October 1-15, January 1-15, April 1-15 and July 1-15.
Office of Pharmacy Affairs Director Presents to 340B Coalition video
By May 15, manufacturers are asked to review the database record for each labeler code and submit a manufacturer change request form to 340Bpricing@hrsa.gov if any updates are necessary. Read the Notification to Manufacturers (PDF - 73 KB) sent 04/24/2015
Program Integrity: Best Practices for Hospital Registrations Program Update March 2015
340B Glossary of Terms (PDF - 299 KB)